These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 35469983)

  • 1. FN3 linked nanobubbles as a targeted contrast agent for US imaging of cancer-associated human PD-L1.
    Kumar US; Natarajan A; Massoud TF; Paulmurugan R
    J Control Release; 2022 Jun; 346():317-327. PubMed ID: 35469983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Novel Engineered Small Protein for Positron Emission Tomography Imaging of Human Programmed Death Ligand-1: Validation in Mouse Models and Human Cancer Tissues.
    Natarajan A; Patel CB; Ramakrishnan S; Panesar PS; Long SR; Gambhir SS
    Clin Cancer Res; 2019 Mar; 25(6):1774-1785. PubMed ID: 30373750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engineering of a novel subnanomolar affinity fibronectin III domain binder targeting human programmed death-ligand 1.
    Ramakrishnan S; Natarajan A; Chan CT; Panesar PS; Gambhir SS
    Protein Eng Des Sel; 2019 Dec; 32(5):231-240. PubMed ID: 31612217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A preclinical study: correlation between PD-L1 PET imaging and the prediction of therapy efficacy of MC38 tumor with
    Qin S; Yu Y; Guan H; Yang Y; Sun F; Sun Y; Zhu J; Xing L; Yu J; Sun X
    Aging (Albany NY); 2021 Apr; 13(9):13006-13022. PubMed ID: 33910164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-invasive assessment of murine PD-L1 levels in syngeneic tumor models by nuclear imaging with nanobody tracers.
    Broos K; Keyaerts M; Lecocq Q; Renmans D; Nguyen T; Escors D; Liston A; Raes G; Breckpot K; Devoogdt N
    Oncotarget; 2017 Jun; 8(26):41932-41946. PubMed ID: 28410210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted Nanobubbles of PD-L1 mAb Combined with Doxorubicin as a Synergistic Tumor Repressor in Hepatocarcinoma.
    Chen Y; Luo X; Liu Y; Zou Y; Yang S; Liu C; Zhao Y
    Int J Nanomedicine; 2022; 17():3989-4008. PubMed ID: 36105615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction of Nucleolin-Targeted Lipid Nanobubbles and Contrast-Enhanced Ultrasound Molecular Imaging in Triple-Negative Breast Cancer.
    Fang K; Wang L; Huang H; Lan M; Shen D; Dong S; Guo Y
    Pharm Res; 2020 Jul; 37(7):145. PubMed ID: 32666304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultrasound molecular imaging as a non-invasive companion diagnostic for netrin-1 interference therapy in breast cancer.
    Wischhusen J; Wilson KE; Delcros JG; Molina-Peña R; Gibert B; Jiang S; Ngo J; Goldschneider D; Mehlen P; Willmann JK; Padilla F
    Theranostics; 2018; 8(18):5126-5142. PubMed ID: 30429890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune/Hypoxic Tumor Microenvironment Regulation-Enhanced Photodynamic Treatment Realized by pH-Responsive Phase Transition-Targeting Nanobubbles.
    Zhao M; Yang X; Fu H; Chen C; Zhang Y; Wu Z; Duan Y; Sun Y
    ACS Appl Mater Interfaces; 2021 Jul; 13(28):32763-32779. PubMed ID: 34235912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CAIX aptamer-functionalized targeted nanobubbles for ultrasound molecular imaging of various tumors.
    Zhu L; Wang L; Liu Y; Xu D; Fang K; Guo Y
    Int J Nanomedicine; 2018; 13():6481-6495. PubMed ID: 30410333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A human programmed death-ligand 1-expressing mouse tumor model for evaluating the therapeutic efficacy of anti-human PD-L1 antibodies.
    Huang A; Peng D; Guo H; Ben Y; Zuo X; Wu F; Yang X; Teng F; Li Z; Qian X; Qin FX
    Sci Rep; 2017 Feb; 7():42687. PubMed ID: 28202921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimized Anti-Prostate-Specific Membrane Antigen Single-Chain Variable Fragment-Loaded Nanobubbles as a Novel Targeted Ultrasound Contrast Agent for the Diagnosis of Prostate Cancer.
    Ding Y; Cao Q; Qian S; Chen X; Xu Y; Chen J; Shen H
    J Ultrasound Med; 2020 Apr; 39(4):761-773. PubMed ID: 31702068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-human PD-L1 Nanobody for Immuno-PET Imaging: Validation of a Conjugation Strategy for Clinical Translation.
    Bridoux J; Broos K; Lecocq Q; Debie P; Martin C; Ballet S; Raes G; Neyt S; Vanhove C; Breckpot K; Devoogdt N; Caveliers V; Keyaerts M; Xavier C
    Biomolecules; 2020 Sep; 10(10):. PubMed ID: 33003481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanobubbles containing PD-L1 Ab and miR-424 mediated PD-L1 blockade, and its expression inhibition to enable and potentiate hepatocellular carcinoma immunotherapy in mice.
    Liu Y; Xie Q; Ma Y; Lin C; Li J; Hu B; Liu C; Zhao Y
    Int J Pharm; 2022 Dec; 629():122352. PubMed ID: 36374798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and Imaging Investigation of Dual-targeted C
    Du J; Li XY; Hu H; Xu L; Yang SP; Li FH
    Sci Rep; 2018 Mar; 8(1):3887. PubMed ID: 29497045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In Vivo Evaluation and Dosimetry Estimate for a High Affinity Affibody PET Tracer Targeting PD-L1.
    Rubins DJ; Meng X; McQuade P; Klimas M; Getty K; Lin SA; Connolly BM; O'Malley SS; Haley H; Purcell M; Gantert L; Holahan M; Lindgren J; Eklund P; Ekblad C; Frejd FY; Hostetler ED; González Trotter DE; Evelhoch JL
    Mol Imaging Biol; 2021 Apr; 23(2):241-249. PubMed ID: 33098025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular Imaging of PD-L1 Expression and Dynamics with the Adnectin-Based PET Tracer
    Stutvoet TS; van der Veen EL; Kol A; Antunes IF; de Vries EFJ; Hospers GAP; de Vries EGE; de Jong S; Lub-de Hooge MN
    J Nucl Med; 2020 Dec; 61(12):1839-1844. PubMed ID: 32358092
    [No Abstract]   [Full Text] [Related]  

  • 18. In vivo positron emission tomography imaging for PD-L1 expression in cancer using aptamer.
    Choi YJ; Park JY; Cho YL; Chae JR; Cho H; Kang WJ
    Biochem Biophys Res Commun; 2022 Sep; 620():105-112. PubMed ID: 35780578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methotrexate-loaded PLGA nanobubbles for ultrasound imaging and Synergistic Targeted therapy of residual tumor during HIFU ablation.
    Zhang X; Zheng Y; Wang Z; Huang S; Chen Y; Jiang W; Zhang H; Ding M; Li Q; Xiao X; Luo X; Wang Z; Qi H
    Biomaterials; 2014 Jun; 35(19):5148-61. PubMed ID: 24680663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Near-infrared fluorescence-labeled anti-PD-L1-mAb for tumor imaging in human colorectal cancer xenografted mice.
    Zhang M; Jiang H; Zhang R; Jiang H; Xu H; Pan W; Gao X; Sun Z
    J Cell Biochem; 2019 Jun; 120(6):10239-10247. PubMed ID: 30609118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.